Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Carbylan Therapeutics, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Carbylan Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Carbylan Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is KALV. The reporting company's CIK number is 1348911.
The total value of stock buying since 2005 is $42,266,904.
The total value of stock sales since 2005 is $30,040,759.
The total value of stock option exercises since 2005 is $338,242.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-10-12||Shah Rajeev M.||Buy||850,000||8.50||7,225,000|
|2017-10-12||Novo Holdings A/s (10% Owner)||Sale||1,726,481||9.26||15,987,214|
|2017-10-12||Aldrich Richard (Director)||Buy||565,065||8.61||4,866,904|
|2017-10-11||Novo Holdings A/s (10% Owner)||Sale||35,519||10.21||362,755|
|2017-10-10||Novo Holdings A/s (10% Owner)||Sale||963,283||12.78||12,309,793|
|2017-09-15||Novo Holdings A/s (10% Owner)||Sale||140,747||7.50||1,055,883|
|2017-09-14||Novo Holdings A/s (10% Owner)||Sale||10,000||8.05||80,500|
|2017-09-13||Novo Holdings A/s (10% Owner)||Sale||25,900||8.02||207,614|
|2016-11-21||Maroney Marcee (VP, Clinical Affairs)||Option Ex||4,664||7.84||36,565|
|2016-11-21||Renzi David (President & CEO)||Option Ex||36,640||7.84||287,257|
|2016-11-21||Basta Steven L||Option Ex||1,125||7.84||8,820|
|2015-12-30||Renzi David (President & CEO)||Sale||10,000||3.70||37,000|
|2015-12-30||Renzi David (President & CEO)||Option Ex||10,000||.56||5,600|
|2015-04-14||Vivo Ventures Vi Affiilates Fund, L.p. (10% Owner)||Buy||1,012,500||5.00||5,062,500|
|2015-04-14||Cha Albert (Director)||Buy||1,012,500||5.00||5,062,500|
|2015-04-14||Nasr Khaled (10% Owner)||Buy||810,000||5.00||4,050,000|
|2015-04-14||Nohra Guy P (Director)||Buy||877,500||5.00||4,387,500|
|2015-04-14||Janney Daniel (10% Owner)||Buy||877,500||5.00||4,387,500|
Insider trading activities including stock purchases, stock sales, and option exercises of KALV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Carbylan Therapeutics, Inc. (symbol KALV, CIK number 1348911) see the Securities and Exchange Commission (SEC) website.